News

The research will leverage Tokyo Tech’s TSUBAME2.0 supercomputer for the discovery of drugs for patients suffering from dengue fever/dengue hemorrhagic fever. The first step of the collaborative research

The low-volume viscosupplement product was approved as a pain reliever that improves knee joint function in a single injection. Zimmer senior vice president David Nolan said, "Gel-One Hyaluronate

NEB is a privately held company focused on the discovery and production of enzymes for molecular biology applications in the life science industry. The Singapore office general manager

The firm, in the first quarter of 2012, had initially implemented the software’s first phase, which aims to comply with new short cycle dispensing regulations that requires 14-day

Quito-based Takeda Ecuador will carry out sales and marketing operations of the company’s products in the region. Carlos Haro who previously served as general manager for Sanofi, is

Cartagenia’s BENCHlab CNV solution helps labs to deploy microarray testing for prenatal diagnosis, as well as a seamless transition from prenatal to continued post-natal follow-up. The product will

DMD is a pediatric rare disease that affects approximately one in 3,600 boys worldwide, and is caused by a genetic mutation that renders boys unable to make functional

KLH is an immune-stimulating protein used in a range of therapeutic and diagnostic markets, according to the company. The proprietary information on the manufacturing and safety of a

Everolimus is the sixth treatment that NICE has turned down for patients with advanced breast cancer since 20 November 2006. Everolimus is the first new licensed therapeutic drug